{"title":"Ready to Ship","description":"","products":[{"product_id":"glow-blend","title":"Glow – 70mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGLOW\u003c\/strong\u003e pairs three of the most-studied regenerative peptides — \u003cstrong\u003eGHK-Cu, BPC-157 and TB-500\u003c\/strong\u003e — for a skin-and-tissue blend that targets appearance and repair together.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e drives collagen\/elastin synthesis and, in controlled aged-skin studies, improved elasticity and reduced wrinkles\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e add the repair layer: in preclinical research BPC-157 accelerated tendon-cell migration\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e and TB-500 (thymosin β4) drove endothelial migration and angiogenesis\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45392645095586,"sku":"GLOW","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Glow70mg0001.png?v=1757441389"},{"product_id":"bpc-157-10mg","title":"BPC-157 – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e (Body Protection Compound) is a stable pentadecapeptide derived from a protein found in gastric juice, studied for its broad \u003cstrong\u003etissue-repair\u003c\/strong\u003e activity across tendon, ligament, gut and vascular tissue.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003epreclinical research\u003c\/strong\u003e, BPC-157 accelerated the outgrowth and \u003cstrong\u003emigration of tendon fibroblasts\u003c\/strong\u003e and improved their survival under oxidative stress, via the FAK–paxillin pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is also strongly \u003cstrong\u003epro-angiogenic\u003c\/strong\u003e: in rat and endothelial-cell models it promoted new blood-vessel formation and blood-flow recovery by up-regulating the \u003cstrong\u003eVEGFR2–Akt–eNOS\u003c\/strong\u003e pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1007\/s00109-016-1488-y\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45392646439074,"sku":"BC10","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/BPC-15710mg001.png?v=1761485058"},{"product_id":"cagrilintide-10mg","title":"Cagrilintide – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e is a long-acting analog of \u003cstrong\u003eamylin\u003c\/strong\u003e — a pancreatic satiety hormone — acting on the \u003cstrong\u003eamylin receptor\u003c\/strong\u003e. It works through a satiety pathway that is \u003cstrong\u003edistinct from, and complementary to, GLP-1\u003c\/strong\u003e, which is why it is widely studied both alone and stacked with GLP-1 agonists.\u003c\/p\u003e\n\u003cp\u003eIn a 26-week \u003cstrong\u003ePhase 2\u003c\/strong\u003e obesity trial, cagrilintide 4.5 mg produced a mean \u003cstrong\u003ebody-weight reduction of 10.8%\u003c\/strong\u003e, versus 3.0% on placebo — and it \u003cstrong\u003eoutperformed liraglutide 3.0 mg\u003c\/strong\u003e (10.8% vs 9.0%)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(21)01751-7\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts most-studied use is in \u003cstrong\u003ecombination\u003c\/strong\u003e: co-administered with semaglutide (\u003cstrong\u003eCagriSema\u003c\/strong\u003e), weight loss reached \u003cstrong\u003e15.6%\u003c\/strong\u003e at 32 weeks — far beyond semaglutide alone (5.1%)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01163-7\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the cagrilintide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45413000446114,"sku":"CGL10","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Cagrilintide10mg001.png?v=1747398509"},{"product_id":"melanotan-ii-10mg","title":"Melanotan II – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eMelanotan II\u003c\/strong\u003e is a synthetic, cyclic analog of \u003cstrong\u003eα-MSH\u003c\/strong\u003e (α-melanocyte-stimulating hormone) that activates melanocortin receptors — most notably \u003cstrong\u003eMC1R\u003c\/strong\u003e on skin melanocytes, driving melanin production (pigmentation).\u003c\/p\u003e\n\u003cp\u003eIn a human \u003cstrong\u003ePhase I study\u003c\/strong\u003e, subcutaneous MT-II increased skin pigmentation (measured by quantitative reflectance) after only a few low doses, alongside central melanocortin effects\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/0024-3205(96)00160-9\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eMelanotan II is an \u003cstrong\u003eunlicensed research compound\u003c\/strong\u003e and its long-term safety is not established; it is provided strictly for laboratory research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical (Phase I) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45413259739298,"sku":"ML10","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/MelanotanII10mg001.png?v=1747398544"},{"product_id":"nad-500mg","title":"NAD+ 500mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eNAD+\u003c\/strong\u003e (nicotinamide adenine dinucleotide) is an \u003cstrong\u003eessential coenzyme\u003c\/strong\u003e at the center of mitochondrial energy production, \u003cstrong\u003esirtuin\u003c\/strong\u003e (longevity-enzyme) activity and DNA repair — and its levels \u003cstrong\u003edecline with age\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a randomized, double-blind, placebo-controlled human trial, chronic supplementation with the NAD+ precursor \u003cstrong\u003enicotinamide riboside\u003c\/strong\u003e was \u003cstrong\u003ewell tolerated and effectively raised NAD+ metabolism\u003c\/strong\u003e in healthy middle-aged and older adults, with early signals toward lower blood pressure and arterial stiffness\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-018-03421-7\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBy replenishing the NAD+ pool that fuels \u003cstrong\u003esirtuins and PARP DNA-repair enzymes\u003c\/strong\u003e, NAD+ research targets cellular energy, metabolism and aging biology.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on NAD+ precursor supplementation and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45413266063522,"sku":"NJ500","price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/NAD500mg001.png?v=1747398580"},{"product_id":"tirzepatide-30mg","title":"Tirzepatide – 30mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45432090034338,"sku":"T30","price":170.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Tirzepatide30mg001.png?v=1747398392"},{"product_id":"sg-10mg","title":"GLP-1SG – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e is the most extensively studied \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e — a single, highly selective incretin-pathway agonist that has become the reference standard against which newer dual and triple agonists are measured. It acts on appetite signaling, glucose-dependent insulin release and gastric emptying.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 68-week \u003cstrong\u003eSTEP 1\u003c\/strong\u003e obesity trial, participants on 2.4 mg recorded a mean \u003cstrong\u003ebody-weight reduction of 14.9%\u003c\/strong\u003e, versus 2.4% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e50%\u003c\/strong\u003e lost 15% or more of their body weight, and \u003cstrong\u003e69%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts evidence base runs deep: in \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e (SUSTAIN 1) semaglutide cut HbA1c by \u003cstrong\u003e1.55 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S2213-8587(17)30013-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, and in the 17,604-patient \u003cstrong\u003eSELECT\u003c\/strong\u003e cardiovascular trial it reduced major cardiac events by \u003cstrong\u003e20%\u003c\/strong\u003e in adults with obesity and no diabetes\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2307563\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the semaglutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45432097865890,"sku":"SM10","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Semaglutide10mg001_a30dfb74-391e-4810-971b-7f1693d5dd75.png?v=1763812877"},{"product_id":"tirzepatide-5mg","title":"Tirzepatide – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45436972597410,"sku":"T05","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Tirzepatide5mg001.png?v=1747398221"},{"product_id":"tirzepatide-10mg","title":"Tirzepatide – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003edual GIP and GLP-1 receptor agonist\u003c\/strong\u003e — a single molecule that activates two incretin pathways at once. In peptide research this dual mechanism has drawn intense interest for its effects on appetite signaling, insulin response and \u003cstrong\u003ebody-weight regulation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 72-week \u003cstrong\u003eSURMOUNT-1\u003c\/strong\u003e trial, participants on the 15 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 20.9%\u003c\/strong\u003e, versus 3.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e57%\u003c\/strong\u003e of that group lost a fifth or more of their body weight, and \u003cstrong\u003e91%\u003c\/strong\u003e lost at least 5%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2206038\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eHead-to-head data reinforce the signal: in \u003cstrong\u003eSURPASS-2\u003c\/strong\u003e, tirzepatide produced greater weight loss than semaglutide — up to \u003cstrong\u003e5.5 kg more\u003c\/strong\u003e at the top dose — while lowering HbA1c by \u003cstrong\u003e2.30 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2107519\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e. Its dual-receptor design is widely cited as why it outperforms single-pathway GLP-1 agonists\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/oby.23612\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the tirzepatide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45436979216546,"sku":"T10","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Tirzepatide10mg001.png?v=1747398263"},{"product_id":"tb-500-thymosin-beta-4-43-aa-5mg","title":"TB-500 – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e is the full \u003cstrong\u003e43-amino-acid thymosin β4\u003c\/strong\u003e peptide — a naturally occurring actin-regulating protein central to \u003cstrong\u003ecell migration\u003c\/strong\u003e and tissue repair.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003epreclinical research\u003c\/strong\u003e, thymosin β4 acted as a potent chemoattractant, accelerating \u003cstrong\u003eendothelial-cell migration four- to six-fold\u003c\/strong\u003e and promoting angiogenesis\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn rodent models it promoted \u003cstrong\u003eangiogenesis and wound repair\u003c\/strong\u003e in both young and aged animals, alongside effects on hair-follicle development\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.mad.2003.11.005\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45436980199586,"sku":"TB5","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/TB-5005mg001.png?v=1747398709"},{"product_id":"sg-5mg","title":"GLP-1SG – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e is the most extensively studied \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e — a single, highly selective incretin-pathway agonist that has become the reference standard against which newer dual and triple agonists are measured. It acts on appetite signaling, glucose-dependent insulin release and gastric emptying.\u003c\/p\u003e\n\u003cp\u003eIn the landmark 68-week \u003cstrong\u003eSTEP 1\u003c\/strong\u003e obesity trial, participants on 2.4 mg recorded a mean \u003cstrong\u003ebody-weight reduction of 14.9%\u003c\/strong\u003e, versus 2.4% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e50%\u003c\/strong\u003e lost 15% or more of their body weight, and \u003cstrong\u003e69%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2032183\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIts evidence base runs deep: in \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e (SUSTAIN 1) semaglutide cut HbA1c by \u003cstrong\u003e1.55 points\u003c\/strong\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S2213-8587(17)30013-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, and in the 17,604-patient \u003cstrong\u003eSELECT\u003c\/strong\u003e cardiovascular trial it reduced major cardiac events by \u003cstrong\u003e20%\u003c\/strong\u003e in adults with obesity and no diabetes\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2307563\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the semaglutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45436982460578,"sku":"SM5","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Semaglutide5mg001_866be3bc-cb15-4610-b328-62ea94c3ba0d.png?v=1763812807"},{"product_id":"ghk-cu-50mg","title":"GHK-Cu – 50mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is the human copper-binding tripeptide (glycyl-L-histidyl-L-lysine + copper) — a natural signal for \u003cstrong\u003eskin remodeling and repair\u003c\/strong\u003e whose levels decline with age.\u003c\/p\u003e\n\u003cp\u003eIn controlled studies on aged skin, GHK-Cu \u003cstrong\u003etightened skin, improved elasticity and firmness, and reduced fine lines, wrinkles and photodamage\u003c\/strong\u003e; mechanistically it boosts collagen and elastin synthesis and fibroblast proliferation\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBeyond skin, GHK-Cu acts as a broad regenerative signal — \u003cstrong\u003eantioxidant and anti-inflammatory\u003c\/strong\u003e — and up- and down-regulates a large set of human genes tied to tissue repair\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45436983443618,"sku":"CU50","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/50mg0001.png?v=1757441335"},{"product_id":"retatrutide-6mg","title":"Retatrutide – 6mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45720021467298,"sku":"RT7-A","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Retatrutide-6mg001.png?v=1753882084"},{"product_id":"retatrutide-12mg","title":"Retatrutide – 12mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45720021860514,"sku":"RT14-A","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Retatrutide-12mg001.png?v=1753882048"},{"product_id":"retatrutide-24mg","title":"Retatrutide – 24mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e is a first-in-class \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e — a single molecule that activates the \u003cstrong\u003eGIP\u003c\/strong\u003e, \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptors at once. The added glucagon arm is thought to raise \u003cstrong\u003eenergy expenditure\u003c\/strong\u003e on top of the appetite reduction driven by GIP and GLP-1\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2022.07.013\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a 48-week \u003cstrong\u003ePhase 2 obesity trial\u003c\/strong\u003e, participants on the 12 mg dose recorded a mean \u003cstrong\u003ebody-weight reduction of 24.2%\u003c\/strong\u003e, versus 2.1% on placebo\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003e83%\u003c\/strong\u003e of that group lost 15% or more of their body weight, and \u003cstrong\u003e93%\u003c\/strong\u003e lost at least 10%\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a separate \u003cstrong\u003ePhase 2 type-2-diabetes trial\u003c\/strong\u003e, retatrutide lowered HbA1c by up to \u003cstrong\u003e2.02 points\u003c\/strong\u003e and cut body weight by about \u003cstrong\u003e16.9%\u003c\/strong\u003e at 36 weeks — outperforming the GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01053-X\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a single vial containing \u003cstrong\u003e24 mg\u003c\/strong\u003e of lyophilized retatrutide powder for reconstitution. \u003cem\u003eFigures above summarize published clinical findings on the retatrutide molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45720022155426,"sku":"RT26-A","price":195.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Retatrutide-24mg001.png?v=1753882013"},{"product_id":"klow-70mg","title":"Klow – 80mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eKLOW\u003c\/strong\u003e combines four peptides — \u003cstrong\u003eKPV, GHK-Cu, BPC-157 and TB-500\u003c\/strong\u003e — spanning inflammation, skin and tissue repair in a single blend.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e (derived from α-MSH) is the anti-inflammatory arm: in murine models it significantly reduced inflammation and sped recovery\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1002\/ibd.20334\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e adds skin remodeling — collagen, elasticity and reduced wrinkles in controlled studies\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e complete the repair layer, accelerating cell migration and angiogenesis in preclinical research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[4]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical and cosmetic research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides - USA","offers":[{"title":"Default Title","offer_id":45820193931426,"sku":"KLOW","price":170.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/KLOWPRIMELAB.png?v=1757691631"},{"product_id":"sermorelin-5mg","title":"Sermorelin — 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSermorelin\u003c\/strong\u003e is \u003cstrong\u003eGHRH (1-29)\u003c\/strong\u003e — the shortest fully active fragment of growth-hormone-releasing hormone. It prompts the pituitary to release the body’s \u003cstrong\u003eown growth hormone\u003c\/strong\u003e in natural pulses, rather than supplying synthetic GH.\u003c\/p\u003e\n\u003cp\u003eIn a randomized trial of age-advanced adults, nightly GHRH (1-29) significantly raised \u003cstrong\u003enocturnal GH and IGF-1\u003c\/strong\u003e within two weeks, and increased \u003cstrong\u003elean body mass\u003c\/strong\u003e and skin thickness over 16 weeks\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.82.5.3943\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause it works through the natural \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e, growth-hormone output stays under the body’s own feedback control — a key contrast with exogenous GH.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46288941351074,"sku":"Serm-5","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/PRIMELAB_POWDER_SERMORELIN5MG.png?v=1762509472"},{"product_id":"sermorelin-10mg","title":"Sermorelin — 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSermorelin\u003c\/strong\u003e is \u003cstrong\u003eGHRH (1-29)\u003c\/strong\u003e — the shortest fully active fragment of growth-hormone-releasing hormone. It prompts the pituitary to release the body’s \u003cstrong\u003eown growth hormone\u003c\/strong\u003e in natural pulses, rather than supplying synthetic GH.\u003c\/p\u003e\n\u003cp\u003eIn a randomized trial of age-advanced adults, nightly GHRH (1-29) significantly raised \u003cstrong\u003enocturnal GH and IGF-1\u003c\/strong\u003e within two weeks, and increased \u003cstrong\u003elean body mass\u003c\/strong\u003e and skin thickness over 16 weeks\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.82.5.3943\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause it works through the natural \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e, growth-hormone output stays under the body’s own feedback control — a key contrast with exogenous GH.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46288942694562,"sku":"SMO10","price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/PRIMELAB_POWDER_SERMORELIN10MG.png?v=1762509545"},{"product_id":"grow-h-10mg-cjc-1295-no-dac-ipamorelin","title":"Grow-H – 10mg (CJC-1295 no DAC \u0026 Ipamorelin)","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGROW-H\u003c\/strong\u003e pairs \u003cstrong\u003eCJC-1295 (No DAC)\u003c\/strong\u003e and \u003cstrong\u003eIpamorelin\u003c\/strong\u003e (5 mg each) — a GHRH analog plus a GHRP — the classic “amplify from two receptors” stack.\u003c\/p\u003e\n\u003cp\u003eIn healthy adults, \u003cstrong\u003eCJC-1295\u003c\/strong\u003e produced sustained increases in GH (\u003cstrong\u003e2- to 10-fold\u003c\/strong\u003e) and IGF-1 (\u003cstrong\u003e1.5- to 3-fold\u003c\/strong\u003e) lasting days per dose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jc.2005-1536\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e adds a selective GH pulse \u003cstrong\u003ewithout the cortisol spike\u003c\/strong\u003e of older secretagogues\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e, so the two together drive a larger, cleaner release than either alone.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical (CJC-1295) and preclinical (Ipamorelin) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46288962125986,"sku":"CP10","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Primelab_Powder_GROW-H.png?v=1762509808"},{"product_id":"selank-5-mg","title":"Selank – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSelank\u003c\/strong\u003e is a synthetic analog of the immune peptide \u003cstrong\u003etuftsin\u003c\/strong\u003e — an anxiolytic neuropeptide studied for calm and cognition without the drawbacks of classical sedatives.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, Selank produced an \u003cstrong\u003eanxiolytic effect comparable to benzodiazepines\u003c\/strong\u003e (diazepam) in stress models — but \u003cstrong\u003ewithout the sedation or dependence\u003c\/strong\u003e associated with them\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2017\/5091027\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is thought to act by modulating \u003cstrong\u003eGABA and serotonin signaling\u003c\/strong\u003e and BDNF expression, and is investigated for anxiety, focus and memory research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333239951522,"sku":"SK5","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Selank-5-mg0001.png?v=1763742473"},{"product_id":"semax-5-mg","title":"Semax – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eSemax\u003c\/strong\u003e is a synthetic heptapeptide analog of the \u003cstrong\u003eACTH (4-10)\u003c\/strong\u003e fragment — but with the hormonal (corticotropic) activity removed, leaving a \u003cstrong\u003enon-hormonal neuropeptide\u003c\/strong\u003e studied for cognition and neuroprotection.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, a single dose of Semax raised hippocampal \u003cstrong\u003eBDNF ~1.4×\u003c\/strong\u003e and tripled BDNF mRNA (with matching increases in its trkB receptor), alongside improved learning in behavioural tests\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBy amplifying the \u003cstrong\u003eBDNF\/trkB neuroplasticity system\u003c\/strong\u003e, it is investigated for memory, focus, stroke recovery and mood research — typically via intranasal delivery.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333247619234,"sku":"XA5","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Semax-5-mg0001.png?v=1763742982"},{"product_id":"tesamorelin-10-mg","title":"Tesamorelin – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a \u003cstrong\u003estabilized GHRH analog\u003c\/strong\u003e, and the only GHRH analog whose molecule has reached approval as a \u003cstrong\u003eprescription medicine\u003c\/strong\u003e (Egrifta) — an approval that covers that finished drug product, not the research material supplied here. It has been studied specifically for deep abdominal (visceral) fat.\u003c\/p\u003e\n\u003cp\u003eIn a randomized human trial, daily tesamorelin reduced \u003cstrong\u003evisceral adipose tissue by 18%\u003c\/strong\u003e over 52 weeks and lowered triglycerides, without clinically significant changes in glucose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1097\/QAD.0b013e32830a5058\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt acts on the pituitary \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e to restore GH\/IGF-1 signaling; visceral fat re-accumulates once treatment stops, underlining that the effect is treatment-dependent.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333254369442,"sku":"TSM10","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Tesamorelin-10-mg0001.png?v=1763743342"},{"product_id":"ipamorelin-10-mg","title":"Ipamorelin – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e is a pentapeptide \u003cstrong\u003eghrelin-receptor (GHS-R) agonist\u003c\/strong\u003e — a growth-hormone-releasing peptide that triggers a clean pulse of GH.\u003c\/p\u003e\n\u003cp\u003eIn the study that introduced it, ipamorelin released GH with a potency matching earlier GHRPs but — uniquely — \u003cstrong\u003ewithout raising cortisol or prolactin\u003c\/strong\u003e, even at 200× the effective dose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. That selectivity is its defining feature.\u003c\/p\u003e\n\u003cp\u003eIt pairs naturally with a \u003cstrong\u003eGHRH analog\u003c\/strong\u003e such as CJC-1295: the two act on different receptors to amplify the growth-hormone pulse.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal and cell-based) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333259153570,"sku":"IP10","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/Ipamorelin-10-mg0001.png?v=1763743499"},{"product_id":"mots-c-10-mg","title":"MOTS-C – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is a \u003cstrong\u003e16-amino-acid mitochondrial-derived peptide\u003c\/strong\u003e — encoded inside the mitochondrial genome itself — that acts as a metabolic signal often described as an \u003cstrong\u003e“exercise mimetic.”\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, MOTS-c treatment \u003cstrong\u003eprevented high-fat-diet-induced obesity\u003c\/strong\u003e and both \u003cstrong\u003eage- and diet-induced insulin resistance\u003c\/strong\u003e in mice, acting through \u003cstrong\u003eAMPK activation\u003c\/strong\u003e in skeletal muscle\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.cmet.2015.02.009\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eExercise raises the body’s own MOTS-c in human muscle and blood; in mice, MOTS-c treatment \u003cstrong\u003eenhanced physical performance\u003c\/strong\u003e across young, middle-aged and old animals\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-020-20790-0\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e — which is why it is studied for metabolic health and healthspan research.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal and cell-based) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333262921890,"sku":"MS10","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/MOTS-C-10-mg0001.png?v=1763743693"},{"product_id":"b12-10-mg","title":"B12 – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eVitamin B12\u003c\/strong\u003e (cyanocobalamin) is a water-soluble \u003cstrong\u003ecofactor\u003c\/strong\u003e at the centre of cellular energy metabolism, the \u003cstrong\u003emethylation cycle\u003c\/strong\u003e, DNA synthesis and red-blood-cell formation — one of the most fundamental molecules in metabolic research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/nrdp.2017.40\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBiochemically it serves two enzymes: \u003cstrong\u003emethionine synthase\u003c\/strong\u003e, which remethylates \u003cstrong\u003ehomocysteine to methionine\u003c\/strong\u003e and regenerates the cell’s methyl-donor pool, and \u003cstrong\u003emethylmalonyl-CoA mutase\u003c\/strong\u003e in mitochondrial energy metabolism\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/nrdp.2017.40\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMcp1113996\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBecause B12 status governs homocysteine, it features in cognition research: in the randomized, placebo-controlled \u003cstrong\u003eVITACOG\u003c\/strong\u003e trial, homocysteine-lowering B vitamins (including B12) \u003cstrong\u003eslowed the rate of brain atrophy\u003c\/strong\u003e in older adults with mild cognitive impairment — an effect concentrated in those with elevated baseline homocysteine\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0012244\" target=\"_blank\" rel=\"noopener\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published biochemical and clinical research on the vitamin B12 molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333274718370,"sku":"B12","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/B12-10-mg0001_1fb18620-3231-4b83-85f9-b8190a5234f3.png?v=1763991476"},{"product_id":"bpc-157-tb-500-5-mg-5-mg","title":"BPC-157 \/ TB-500 – 5mg \/ 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003eThis blend pairs \u003cstrong\u003eBPC-157\u003c\/strong\u003e and \u003cstrong\u003eTB-500\u003c\/strong\u003e (5 mg each) — two of the most-studied repair peptides — chosen for their \u003cstrong\u003ecomplementary mechanisms\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e has shown localized effects on tendon, ligament and gut tissue and strong pro-angiogenic activity in preclinical models\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1152\/japplphysiol.00945.2010\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e (thymosin β4) drives systemic \u003cstrong\u003ecell migration and angiogenesis\u003c\/strong\u003e, accelerating endothelial migration several-fold in preclinical research\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a two-peptide \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333287366818,"sku":"BB10","price":80.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/BPC-157-TB-5005mg0001.png?v=1763744430"},{"product_id":"ghk-cu-100-mg","title":"GHK-Cu – 100mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is the human copper-binding tripeptide (glycyl-L-histidyl-L-lysine + copper) — a natural signal for \u003cstrong\u003eskin remodeling and repair\u003c\/strong\u003e whose levels decline with age.\u003c\/p\u003e\n\u003cp\u003eIn controlled studies on aged skin, GHK-Cu \u003cstrong\u003etightened skin, improved elasticity and firmness, and reduced fine lines, wrinkles and photodamage\u003c\/strong\u003e; mechanistically it boosts collagen and elastin synthesis and fibroblast proliferation\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1163\/156856208784909435\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBeyond skin, GHK-Cu acts as a broad regenerative signal — \u003cstrong\u003eantioxidant and anti-inflammatory\u003c\/strong\u003e — and up- and down-regulates a large set of human genes tied to tissue repair\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1155\/2012\/324832\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published cosmetic and preclinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333300048034,"sku":"CU100","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/GHK-Cu-100-mg0001_b4c2ed0b-6712-4dec-8be5-426d6a9cdbc5.png?v=1763991521"},{"product_id":"orforglipron-6-mg","title":"Orforglipron – 6mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eOrforglipron\u003c\/strong\u003e is the first orally-bioavailable \u003cstrong\u003enon-peptide GLP-1 receptor agonist\u003c\/strong\u003e — a small molecule taken \u003cstrong\u003eonce daily by mouth\u003c\/strong\u003e, with no injection and no food or water restrictions. It targets the same GLP-1 pathway as injectable agonists through a compact synthetic structure.\u003c\/p\u003e\n\u003cp\u003eIn a 36-week \u003cstrong\u003ePhase 2\u003c\/strong\u003e obesity trial, oral orforglipron produced up to a \u003cstrong\u003e14.7% body-weight reduction\u003c\/strong\u003e, versus 2.3% on placebo — with \u003cstrong\u003e46–75%\u003c\/strong\u003e of participants losing 10% or more\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1056\/NEJMoa2302392\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003etype-2 diabetes\u003c\/strong\u003e, it lowered HbA1c by up to \u003cstrong\u003e2.10 points\u003c\/strong\u003e and reduced body weight by about \u003cstrong\u003e10 kg\u003c\/strong\u003e, outperforming the injectable GLP-1 agonist dulaglutide\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01302-8\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as \u003cstrong\u003e90 oral capsules\u003c\/strong\u003e. \u003cem\u003eFigures above summarize published clinical findings on the orforglipron molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333319119010,"sku":"ORF(6)-90","price":240.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/PrimeLab_Capsules0001.png?v=1763745148"},{"product_id":"aod-9604-5-mg","title":"AOD-9604 – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eAOD-9604\u003c\/strong\u003e is the \u003cstrong\u003eC-terminal lipolytic fragment of human growth hormone\u003c\/strong\u003e (hGH 176–191) — the fat-metabolism domain of the hormone, isolated from the rest of the molecule.\u003c\/p\u003e\n\u003cp\u003eIn preclinical research, chronic AOD-9604 \u003cstrong\u003esignificantly reduced body-weight gain\u003c\/strong\u003e and increased \u003cstrong\u003efat oxidation and lipolysis\u003c\/strong\u003e in obese mice\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/endo.142.12.8522\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/sj.ijo.0801740\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eCritically, and \u003cem\u003eunlike\u003c\/em\u003e full hGH, AOD-9604 \u003cstrong\u003edid not raise blood glucose or suppress insulin\u003c\/strong\u003e, and it does \u003cstrong\u003enot bind the hGH receptor\u003c\/strong\u003e or the IGF-1 pathway\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/sj.ijo.0801740\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e — separating fat metabolism from growth-hormone side effects.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published preclinical (animal) research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333842555042,"sku":"AOD-5","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/PRIMELAB_POWDER_AOD-9604_5MG.png?v=1763746521"},{"product_id":"pt-141-10-mg","title":"PT-141 – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003ePT-141\u003c\/strong\u003e (bremelanotide) is a cyclic melanocortin peptide that acts on the \u003cstrong\u003eMC3R\/MC4R receptors in the central nervous system\u003c\/strong\u003e — a mechanism distinct from PDE5 inhibitors like sildenafil, which act on blood flow. It works upstream, on the brain’s arousal pathway.\u003c\/p\u003e\n\u003cp\u003eIn two randomized \u003cstrong\u003ePhase 3 trials\u003c\/strong\u003e (RECONNECT, 1,267 women), bremelanotide significantly improved \u003cstrong\u003esexual desire\u003c\/strong\u003e and reduced desire-related distress versus placebo (P\u0026lt;0.001)\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1097\/AOG.0000000000003500\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e. Bremelanotide is approved as a \u003cstrong\u003eprescription medicine\u003c\/strong\u003e (Vyleesi) for premenopausal hypoactive sexual desire disorder; that approval covers the finished drug product and does not carry over to the research material supplied here.\u003c\/p\u003e\n\u003cp\u003eBecause it targets central melanocortin signaling rather than vasculature, it is studied for arousal that begins in the CNS. Reported effects include transient nausea, flushing and headache.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":46333937385634,"sku":"PT-10","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/PRIMELAB_POWDER_PT-141_10MG.png?v=1763746876"},{"product_id":"tesamorelin-20mg","title":"Tesamorelin – 20mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a \u003cstrong\u003estabilized GHRH analog\u003c\/strong\u003e, and the only GHRH analog whose molecule has reached approval as a \u003cstrong\u003eprescription medicine\u003c\/strong\u003e (Egrifta) — an approval that covers that finished drug product, not the research material supplied here. It has been studied specifically for deep abdominal (visceral) fat.\u003c\/p\u003e\n\u003cp\u003eIn a randomized human trial, daily tesamorelin reduced \u003cstrong\u003evisceral adipose tissue by 18%\u003c\/strong\u003e over 52 weeks and lowered triglycerides, without clinically significant changes in glucose\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1097\/QAD.0b013e32830a5058\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIt acts on the pituitary \u003cstrong\u003eGHRH receptor\u003c\/strong\u003e to restore GH\/IGF-1 signaling; visceral fat re-accumulates once treatment stops, underlining that the effect is treatment-dependent.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on this molecule and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540250935458,"sku":"TSM20","price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-tesamorelin-20mg.webp?v=1786971629"},{"product_id":"nad-1000mg","title":"NAD+ 1000mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eNAD+\u003c\/strong\u003e (nicotinamide adenine dinucleotide) is an \u003cstrong\u003eessential coenzyme\u003c\/strong\u003e at the center of mitochondrial energy production, \u003cstrong\u003esirtuin\u003c\/strong\u003e (longevity-enzyme) activity and DNA repair — and its levels \u003cstrong\u003edecline with age\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn a randomized, double-blind, placebo-controlled human trial, chronic supplementation with the NAD+ precursor \u003cstrong\u003enicotinamide riboside\u003c\/strong\u003e was \u003cstrong\u003ewell tolerated and effectively raised NAD+ metabolism\u003c\/strong\u003e in healthy middle-aged and older adults, with early signals toward lower blood pressure and arterial stiffness\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-018-03421-7\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eBy replenishing the NAD+ pool that fuels \u003cstrong\u003esirtuins and PARP DNA-repair enzymes\u003c\/strong\u003e, NAD+ research targets cellular energy, metabolism and aging biology.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFigures above summarize published clinical research on NAD+ precursor supplementation and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540250968226,"sku":"NJ1000","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-nad-1000mg.webp?v=1786971633"},{"product_id":"5-amino-1mq-10mg","title":"5-Amino-1MQ – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e5-Amino-1MQ (5-amino-1-methylquinolinium, also written 5A1MQ) is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), supplied for laboratory research. Unlike the peptides that make up most of this catalog, it is a compact quinolinium compound rather than an amino-acid chain.\u003c\/p\u003e\n\u003cp\u003eNNMT transfers a methyl group from S-adenosyl-L-methionine to nicotinamide, producing 1-methylnicotinamide and S-adenosyl-L-homocysteine. Because nicotinamide also feeds the NAD+ salvage pathway, the enzyme sits at the junction of methyl-donor and NAD+ metabolism, which is what makes it an object of study in metabolic enzymology. Reported selectivity assays for this inhibitor class describe no inhibition of other SAM-dependent methyltransferases or of NAD+ salvage enzymes.\u003c\/p\u003e\n\u003cp\u003ePublished work is preclinical throughout. In cultured adipocytes, inhibitors of this scaffold lower intracellular 1-methylnicotinamide, raise NAD+ and SAM, and suppress lipogenesis. Rodent studies report elevated NNMT expression in white adipose tissue and liver in diet-induced obesity models, and effects of knockdown on adipose NAD+ and SAM, polyamine flux, histone H3K4 methylation and adipocyte oxygen consumption. Genetic Nnmt-deletion studies report sex- and diet-dependent outcomes that only partly overlap with the inhibitor literature, and no human clinical data are published.\u003c\/p\u003e\n\u003cp\u003eThis product is intended for laboratory research use only. It is not for human or veterinary use, diagnostic use, or any form of consumption.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251000994,"sku":"10AM","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-5-amino-1mq-10mg.webp?v=1786971637"},{"product_id":"5-amino-1mq-20mg","title":"5-Amino-1MQ – 20mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e5-Amino-1MQ (5-amino-1-methylquinolinium, also written 5A1MQ) is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), supplied for laboratory research. Unlike the peptides that make up most of this catalog, it is a compact quinolinium compound rather than an amino-acid chain.\u003c\/p\u003e\n\u003cp\u003eNNMT transfers a methyl group from S-adenosyl-L-methionine to nicotinamide, producing 1-methylnicotinamide and S-adenosyl-L-homocysteine. Because nicotinamide also feeds the NAD+ salvage pathway, the enzyme sits at the junction of methyl-donor and NAD+ metabolism, which is what makes it an object of study in metabolic enzymology. Reported selectivity assays for this inhibitor class describe no inhibition of other SAM-dependent methyltransferases or of NAD+ salvage enzymes.\u003c\/p\u003e\n\u003cp\u003ePublished work is preclinical throughout. In cultured adipocytes, inhibitors of this scaffold lower intracellular 1-methylnicotinamide, raise NAD+ and SAM, and suppress lipogenesis. Rodent studies report elevated NNMT expression in white adipose tissue and liver in diet-induced obesity models, and effects of knockdown on adipose NAD+ and SAM, polyamine flux, histone H3K4 methylation and adipocyte oxygen consumption. Genetic Nnmt-deletion studies report sex- and diet-dependent outcomes that only partly overlap with the inhibitor literature, and no human clinical data are published.\u003c\/p\u003e\n\u003cp\u003eThis product is intended for laboratory research use only. It is not for human or veterinary use, diagnostic use, or any form of consumption.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251033762,"sku":"20AM","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-5-amino-1mq-20mg.webp?v=1786971643"},{"product_id":"5-amino-1mq-50mg","title":"5-Amino-1MQ – 50mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e5-Amino-1MQ (5-amino-1-methylquinolinium, also written 5A1MQ) is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), supplied for laboratory research. Unlike the peptides that make up most of this catalog, it is a compact quinolinium compound rather than an amino-acid chain.\u003c\/p\u003e\n\u003cp\u003eNNMT transfers a methyl group from S-adenosyl-L-methionine to nicotinamide, producing 1-methylnicotinamide and S-adenosyl-L-homocysteine. Because nicotinamide also feeds the NAD+ salvage pathway, the enzyme sits at the junction of methyl-donor and NAD+ metabolism, which is what makes it an object of study in metabolic enzymology. Reported selectivity assays for this inhibitor class describe no inhibition of other SAM-dependent methyltransferases or of NAD+ salvage enzymes.\u003c\/p\u003e\n\u003cp\u003ePublished work is preclinical throughout. In cultured adipocytes, inhibitors of this scaffold lower intracellular 1-methylnicotinamide, raise NAD+ and SAM, and suppress lipogenesis. Rodent studies report elevated NNMT expression in white adipose tissue and liver in diet-induced obesity models, and effects of knockdown on adipose NAD+ and SAM, polyamine flux, histone H3K4 methylation and adipocyte oxygen consumption. Genetic Nnmt-deletion studies report sex- and diet-dependent outcomes that only partly overlap with the inhibitor literature, and no human clinical data are published.\u003c\/p\u003e\n\u003cp\u003eThis product is intended for laboratory research use only. It is not for human or veterinary use, diagnostic use, or any form of consumption.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251066530,"sku":"50AM","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-5-amino-1mq-50mg.webp?v=1786971646"},{"product_id":"kpv-5mg","title":"KPV – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e is a synthetic tripeptide composed of lysine, proline and valine, corresponding to residues 11-13 at the C-terminus of alpha-melanocyte-stimulating hormone. It is studied as a structurally minimal fragment of that hormone, which is precisely what makes it useful as a laboratory tool: it allows investigators to ask which properties of the parent sequence persist once the rest of the molecule is removed.\u003c\/p\u003e\n\u003cp\u003eThe published literature on KPV is concentrated in gastrointestinal inflammation research. The reported anti-inflammatory activity is described as independent of the melanocortin receptor MC1R, which distinguishes the fragment from the parent hormone. Cellular entry is described as PepT1-mediated, with the di- and tripeptide transporter of intestinal epithelial and immune cells carrying the intact peptide into the cell. In experimental colitis models, the reported readouts include pro-inflammatory cytokine expression and NF-kB pathway activation.\u003c\/p\u003e\n\u003cp\u003eA second research axis is delivery. Nanoparticle and hydrogel carriers have been used to concentrate the tripeptide at the colon rather than distribute it systemically. A related line of work examines the PepT1 transporter in colitis-associated tumorigenesis models, which is why the transporter itself recurs as a variable in this field.\u003c\/p\u003e\n\u003cp\u003eThe evidence base is in vitro and rodent; no clinical data are presented, and no human dosing or administration route is described anywhere in this material. This product is supplied for laboratory research use only and is not intended for human or veterinary use, diagnostic procedures, or any therapeutic application.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251099298,"sku":"KPV5","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-kpv-5mg.webp?v=1786971651"},{"product_id":"kpv-10mg","title":"KPV – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e is a synthetic tripeptide composed of lysine, proline and valine, corresponding to residues 11-13 at the C-terminus of alpha-melanocyte-stimulating hormone. It is studied as a structurally minimal fragment of that hormone, which is precisely what makes it useful as a laboratory tool: it allows investigators to ask which properties of the parent sequence persist once the rest of the molecule is removed.\u003c\/p\u003e\n\u003cp\u003eThe published literature on KPV is concentrated in gastrointestinal inflammation research. The reported anti-inflammatory activity is described as independent of the melanocortin receptor MC1R, which distinguishes the fragment from the parent hormone. Cellular entry is described as PepT1-mediated, with the di- and tripeptide transporter of intestinal epithelial and immune cells carrying the intact peptide into the cell. In experimental colitis models, the reported readouts include pro-inflammatory cytokine expression and NF-kB pathway activation.\u003c\/p\u003e\n\u003cp\u003eA second research axis is delivery. Nanoparticle and hydrogel carriers have been used to concentrate the tripeptide at the colon rather than distribute it systemically. A related line of work examines the PepT1 transporter in colitis-associated tumorigenesis models, which is why the transporter itself recurs as a variable in this field.\u003c\/p\u003e\n\u003cp\u003eThe evidence base is in vitro and rodent; no clinical data are presented, and no human dosing or administration route is described anywhere in this material. This product is supplied for laboratory research use only and is not intended for human or veterinary use, diagnostic procedures, or any therapeutic application.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251132066,"sku":"KPV10","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-kpv-10mg.webp?v=1786971655"},{"product_id":"dsip-5mg","title":"DSIP – 5mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eDSIP (Delta Sleep-Inducing Peptide)\u003c\/strong\u003e is a synthetic nonapeptide supplied for laboratory research. The peptide takes its name from the experiment in which it was first identified: it was isolated from the cerebral venous blood of rabbits during induced sleep, and the label has followed the molecule ever since.\u003c\/p\u003e\n\u003cp\u003eWhat makes DSIP unusual among research peptides is how much about it remains unknown. Neither its receptor nor its precursor protein has been identified, and the review literature still frames it as an open question rather than a characterized signaling molecule. Reported experimental effects cluster around sleep architecture and EEG measures, hypothalamic-pituitary-adrenal axis activity, stress-response and adaptogenic models, neuroprotection in rodent ischemia work, and hepatocyte and metabolic function.\u003c\/p\u003e\n\u003cp\u003eMost of that record comes from animal models. Human data are limited and largely older, which is precisely why DSIP continues to appear in exploratory neuropeptide and sleep-physiology protocols: it offers a short, fully defined sequence attached to a set of genuinely unresolved questions. In such designs it may serve as a probe or comparator, in studies where the recorded readout, not an established mechanism, is the object of measurement.\u003c\/p\u003e\n\u003cp\u003eThis product is intended for laboratory research use only. It is not a drug, food or cosmetic, and it is not for human or veterinary use.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251164834,"sku":"DS5","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-dsip-5mg.webp?v=1786971658"},{"product_id":"epithalon-10mg","title":"Epithalon – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003eEpithalon, also known as Epitalon or by its sequence designation AEDG (Ala-Glu-Asp-Gly), is a synthetic tetrapeptide modeled on epithalamin, a pineal preparation. Its entire structure is four amino acids, and the research literature built on it is correspondingly narrow in scope.\u003c\/p\u003e\n\u003cp\u003eThat literature concentrates in two areas. In human somatic cell culture, research groups report telomerase activation accompanied by telomere elongation, with related work extending the telomerase question into reproductive cell maturation models. In parallel, studies in aged animal models have examined pineal and circadian rhythm regulation together with neuroendocrine function. The two arms use different assays and different experimental systems, and a result obtained in one does not validate the other.\u003c\/p\u003e\n\u003cp\u003eResearchers should weigh this evidence carefully. Work on Epithalon is dominated by a small number of research groups and sits within experimental gerontology; independent replication is limited, and no receptor, signaling pathway, or epigenetic mechanism is established in the available reports. Findings obtained in vitro or in animal models do not establish what occurs in an intact human organism, and no clinical conclusion follows from a change measured in culture.\u003c\/p\u003e\n\u003cp\u003eThis product is supplied for laboratory research use only. It is not a drug, food, or cosmetic, and it is not intended for human or veterinary use, diagnosis, treatment, or any other application outside a controlled research setting.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251197602,"sku":"ET10","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-epithalon-10mg.webp?v=1786971662"},{"product_id":"epithalon-50mg","title":"Epithalon – 50mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003eEpithalon, also known as Epitalon or by its sequence designation AEDG (Ala-Glu-Asp-Gly), is a synthetic tetrapeptide modeled on epithalamin, a pineal preparation. Its entire structure is four amino acids, and the research literature built on it is correspondingly narrow in scope.\u003c\/p\u003e\n\u003cp\u003eThat literature concentrates in two areas. In human somatic cell culture, research groups report telomerase activation accompanied by telomere elongation, with related work extending the telomerase question into reproductive cell maturation models. In parallel, studies in aged animal models have examined pineal and circadian rhythm regulation together with neuroendocrine function. The two arms use different assays and different experimental systems, and a result obtained in one does not validate the other.\u003c\/p\u003e\n\u003cp\u003eResearchers should weigh this evidence carefully. Work on Epithalon is dominated by a small number of research groups and sits within experimental gerontology; independent replication is limited, and no receptor, signaling pathway, or epigenetic mechanism is established in the available reports. Findings obtained in vitro or in animal models do not establish what occurs in an intact human organism, and no clinical conclusion follows from a change measured in culture.\u003c\/p\u003e\n\u003cp\u003eThis product is supplied for laboratory research use only. It is not a drug, food, or cosmetic, and it is not intended for human or veterinary use, diagnosis, treatment, or any other application outside a controlled research setting.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251230370,"sku":"ET50","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-epithalon-50mg.webp?v=1786971666"},{"product_id":"glutathione-1500mg","title":"Glutathione – 1500mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eGlutathione (GSH)\u003c\/strong\u003e is supplied here as the reduced tripeptide gamma-glutamyl-cysteinyl-glycine, the endogenous intracellular thiol antioxidant. Its defining feature is the free sulfhydryl group of the central cysteine residue, which makes the molecule a substrate for a well-characterized set of enzymes rather than a ligand for a single receptor.\u003c\/p\u003e\n\u003cp\u003eIn published work, glutathione is built intracellularly in two ATP-dependent steps by glutamate-cysteine ligase and glutathione synthetase, with cysteine availability normally limiting the rate. Downstream, the GSH\/GSSG couple buffers the oxidative state of the cell, glutathione peroxidase 4 consumes GSH to reduce lipid hydroperoxides, the step whose failure defines ferroptosis, and glutathione S-transferases conjugate GSH to electrophiles during phase II detoxification.\u003c\/p\u003e\n\u003cp\u003eReported human work is comparatively limited. It centers on deficient glutathione synthesis in aging and on supplementation studies using glycine plus N-acetylcysteine as precursors, results that remain tied to the cohorts and designs that produced them. No outcome in humans is claimed or implied here.\u003c\/p\u003e\n\u003cp\u003eMaterial is intended for controlled laboratory environments and should be handled by qualified personnel following institutional procedures. This product is supplied for laboratory research use only. It is not a drug, food, or cosmetic, and it is not intended for human or veterinary use.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251263138,"sku":"GTT1500","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-glutathione-1500mg.webp?v=1786971670"},{"product_id":"2x-blend-16mg-tesamorelin-ipamorelin","title":"2X Blend – 16mg (Tesamorelin \u0026 Ipamorelin)","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003eThis 2X Blend supplies two growth hormone secretagogues in a single vial: Tesamorelin at 13 mg and Ipamorelin at 3 mg. The two peptides are chemically distinct and act at different receptors, which is the reason they are studied as a pair rather than as interchangeable compounds.\u003c\/p\u003e\n\u003cp\u003eTesamorelin is a stabilized analog of growth hormone-releasing hormone and binds the GHRH receptor on pituitary somatotrophs. Ipamorelin is a selective agonist of the growth hormone secretagogue receptor GHS-R1a, the ghrelin receptor. Published work describes the two receptors as converging on somatotroph secretion through different second-messenger routes, and describes ipamorelin as selective in the specific sense that it did not meaningfully raise cortisol or prolactin in the reported experiments. That selectivity was established for ipamorelin alone.\u003c\/p\u003e\n\u003cp\u003eThe available literature covers each peptide separately. Published work on tesamorelin as a single agent has examined visceral adipose tissue and IGF-1 measures; those results belong to that single-agent context and were not generated with ipamorelin present. No combination-specific potency, ratio optimum or interaction value is stated for this pairing, and study designs using it generally retain single-agent control arms.\u003c\/p\u003e\n\u003cp\u003eSupplied in a single vial for laboratory reconstitution and handling by qualified personnel. This product is intended for laboratory research use only. It is not a drug, is not for human or veterinary use, and is not for diagnostic or therapeutic application.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251295906,"sku":"TI\/13\/3","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-2x-blend-13mg-3mg.webp?v=1786971674"},{"product_id":"tb-500-10mg","title":"TB-500 – 10mg","description":"\u003cdiv class=\"plp-desc-rt\"\u003e\n\u003cstyle\u003e\n.plp-desc-rt{font-family:var(--font-body-family,Helvetica,Arial,sans-serif);color:rgba(18,18,18,.7)}\n.plp-desc-rt p{margin:0 0 15px;font-size:15.5px;font-weight:400;line-height:1.7}\n.plp-desc-rt strong{color:#0e2a44;font-weight:600}\n.plp-desc-rt em{color:rgba(18,18,18,.5)}\n.plp-desc-rt sup{line-height:0}\n.plp-desc-rt sup a{font-size:11px;font-weight:600;color:#2279be;text-decoration:none;padding:0 1px}\n.plp-desc-rt sup a:hover{color:#0e2a44}\n\u003c\/style\u003e\n\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e is the full \u003cstrong\u003e43-amino-acid thymosin β4\u003c\/strong\u003e peptide — a naturally occurring actin-regulating protein central to \u003cstrong\u003ecell migration\u003c\/strong\u003e and tissue repair.\u003c\/p\u003e\n\u003cp\u003eIn \u003cstrong\u003epreclinical research\u003c\/strong\u003e, thymosin β4 acted as a potent chemoattractant, accelerating \u003cstrong\u003eendothelial-cell migration four- to six-fold\u003c\/strong\u003e and promoting angiogenesis\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1096\/fasebj.11.6.9194528\" target=\"_blank\" rel=\"noopener\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eIn rodent models it promoted \u003cstrong\u003eangiogenesis and wound repair\u003c\/strong\u003e in both young and aged animals, alongside effects on hair-follicle development\u003csup\u003e\u003ca href=\"https:\/\/doi.org\/10.1016\/j.mad.2003.11.005\" target=\"_blank\" rel=\"noopener\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp\u003eSupplied as a \u003cstrong\u003elyophilized powder\u003c\/strong\u003e for reconstitution. \u003cem\u003eFindings above come from preclinical (animal and cell-based) research on these molecules and are provided as scientific reference for laboratory research only.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Prime Lab Peptides","offers":[{"title":"Default Title","offer_id":47540251328674,"sku":"TB10","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0665\/6612\/7778\/files\/primelab-tb-500-10mg.webp?v=1786971698"}],"url":"https:\/\/primelabpeptides.com\/collections\/ready-to-ship.oembed?page=2","provider":"Prime Lab Peptides","version":"1.0","type":"link"}